BenevolentAI

BenevolentAI gets $115M to harness AI for new drug discovery
By Jonah Comstock | 02:03 pm | April 20, 2018
BenevolentAI, a UK company using artificial intelligence for drug development, has raised $115 million in new funding, mostly from undisclosed investors in the United States.